Cu-Single Atoms/Clusters-Nanoenzymes Trigger and Integrate Tandem Effect to Synchronously Boost Antifungal and

Mengyang Zhao1, Xiwen Geng1, Qin Zeng1

  • 1Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, P.R. China.

PubMed

Insights

This study introduces Cu-Needs, a novel treatment for fungal keratitis (FK). Cu-Needs enhance corneal penetration, rapidly eliminate fungi, and reduce inflammation, offering a promising strategy for treating this blinding eye infection.

Area of Science:

  • Ophthalmology
  • Materials Science
  • Infectious Diseases

Background:

  • Fungal keratitis (FK) is a severe infectious ocular disease with significant challenges in drug treatment.
  • Current treatments face issues with poor corneal permeability, limited antifungal efficacy, and inadequate inflammation control.

Purpose of the Study:

  • To develop a novel therapeutic agent, Cu-Needs, for effective whole-process intervention of fungal keratitis.
  • To address the limitations of existing FK treatments by enhancing corneal permeability, antifungal activity, and anti-inflammatory effects.

Main Methods:

  • Atomically dispersed Cu-N4 and Cu nanoclusters were loaded onto small-sized, positively charged carbon dots (Cu-SA/NC@CDs) to create Cu-Needs.
  • The ability of Cu-Needs to improve corneal permeability, eliminate fungi via energy depletion, scavenge reactive oxygen species (ROS), and reduce inflammation was evaluated.

Main Results:

  • Cu-Needs demonstrated excellent corneal permeability by temporarily opening tight junctions between corneal cells.
  • Rapid fungal elimination was achieved through energy depletion in fungi during the early stages of FK.
  • Cu-Needs effectively reduced ROS and alleviated corneal inflammation, showing significant therapeutic potential.

Conclusions:

  • Cu-Needs represent a promising strategy for the comprehensive management of fungal keratitis.
  • The designed material exhibits excellent biosafety, including biocompatibility and low toxicity, making it suitable for clinical applications in FK and other infectious diseases.

Related Concept Videos